{"disease":{"id":"iol","name":"iol"},"drugs":{"marketed":[{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in children aged 12 years and older who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-200-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 200 mg","generic_name":"abrocitinib-200-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"JAK inhibitor","quality_score":40,"revenue":"284","mechanism":""},{"drug_id":"rapamune","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamune","company_name":"Wyeth is now a wholly owned subsidiary of Pfizer","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"norethisterone","indication_name":"Secondary physiologic amenorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"f-18","indication_name":"Cardiology","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"F-18","company_name":"3D Imaging Drug","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions."},{"drug_id":"norethindrone-acetate","indication_name":"Secondary physiologic amenorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aygestin","generic_name":"NORETHINDRONE ACETATE","company_name":"Duramed Res","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"medroxyprogesterone","indication_name":"Secondary physiologic amenorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Provera","generic_name":"medroxyprogesterone","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":null,"revenue":null,"mechanism":"Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy."},{"drug_id":"lutetium-177lu-chloride","indication_name":"Radiolabelling of carrier molecules","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lumark","generic_name":"lutetium (177Lu) chloride","company_name":"I.D.B. Radiopharmacy B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"triclabendazole","indication_name":"Infection by Fasciola","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Egaten","generic_name":"TRICLABENDAZOLE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Transthyretin","drug_class":"Anthelmintic [EPC]","quality_score":48,"revenue":null,"mechanism":"Egaten works by binding to and inhibiting the enzyme responsible for the parasite's survival."},{"drug_id":"endometrin","indication_name":"Secondary physiologic amenorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endometrin","generic_name":"progesterone","company_name":"Ferring","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"Progesterone [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"sirolimus","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rapamune","generic_name":"sirolimus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"mTOR Inhibitor Immunosuppressant [EPC]","quality_score":80,"revenue":null,"mechanism":"Rapamune works by binding to the mTOR protein, inhibiting its activity and preventing the growth and proliferation of certain cells."},{"drug_id":"progesteron","indication_name":"Secondary physiologic amenorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Progesteron","company_name":"Minia University","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"clomiphene","indication_name":"Secondary Amenorrhea of Undetermined Etiology","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CLOMIPHENE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"rapamycin","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamycin","company_name":"Institut National de la Santé Et de la Recherche Médicale, France","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"fludeoxyglucose-f-18","indication_name":"Cardiology - Myocardial Metabolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLUDEOXYGLUCOSE F 18","company_name":"","drug_phase":"marketed","molecular_target":"glucose transporter proteins, hexokinase, glucose-6-phosphatase","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":40,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a glucose analog that accumulates in cells with high glucose metabolism, reflecting metabolic activity."},{"drug_id":"fludeoxyglucose","indication_name":"Cardiology","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fludeoxyglucose F-18","generic_name":"FLUDEOXYGLUCOSE","company_name":"Downstate Clincl","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":44,"revenue":null,"mechanism":"Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions."}],"pipeline":[],"offLabel":[],"totalMarketed":17,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03239093","title":"Sixteen Years Trends in Reported Undernutrition in Switzerland","phase":"","overall_status":"COMPLETED","enrollment_count":13297188,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT04786366","title":"Natural History and Patient Journey in Atrial Fibrillation: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals.","phase":"","overall_status":"UNKNOWN","enrollment_count":5601803,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04321486","title":"Natural History and Patient Journey in Dementia: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals.","phase":"","overall_status":"UNKNOWN","enrollment_count":4309481,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04322786","title":"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?","phase":"","overall_status":"UNKNOWN","enrollment_count":1302508,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04670744","title":"Identification of Outcome Relevant Indicators in Routine Data","phase":"","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT06791486","title":"AI-Driven Prediction of Biological Age With EHR","phase":"","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"The Eye Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT02858531","title":"Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics","phase":"","overall_status":"COMPLETED","enrollment_count":760000,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT03773289","title":"Commonly Used Medicines On Neonatal Units in the UK","phase":"","overall_status":"COMPLETED","enrollment_count":642729,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03254472","title":"Big Data Analysis of the Use of bIomarkers Concentration","phase":"","overall_status":"COMPLETED","enrollment_count":585745,"lead_sponsor_name":"Hospital Avicenne","has_results":false},{"nct_id":"NCT04471493","title":"Pediatric and Ambulatory Research in Infectious Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":400000,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT05126641","title":"Analysis of Emergency Department Visits According to Incidence of Covid-19","phase":"","overall_status":"COMPLETED","enrollment_count":400000,"lead_sponsor_name":"Centre Hospitalier de Roubaix","has_results":false},{"nct_id":"NCT03151616","title":"Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":244976,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT03353532","title":"Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":178902,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT05074953","title":"Post-COVID-19 Monitoring in Routine Health Insurance Data","phase":"","overall_status":"COMPLETED","enrollment_count":157134,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT00410475","title":"Cancer Risk in X-Ray Technologists: Second Survey","phase":"","overall_status":"COMPLETED","enrollment_count":146022,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04579237","title":"Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":144625,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT05095844","title":"National Vaccine Adverse Event Reporting Survey and Etiology","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Neuroganics LLC","has_results":false},{"nct_id":"NCT07158983","title":"Evaluation of a Child Health Care Program for Early Identification of Family Violence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06124872","title":"Mapping Snakebite Risk in Kenya and Eswatini","phase":"","overall_status":"UNKNOWN","enrollment_count":70000,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT01088542","title":"The Community Youth Development Study: A Test of Communities That Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52323,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT07021404","title":"The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT07167043","title":"An Explainable Neuroradiologist Artificial Intelligence Assistance System for Brain CT and MRI","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"Yaou Liu","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05261607","title":"Analysis of the Evolution of Mortality in an Intensive Care Unit","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Hospital Universitario Getafe","has_results":false},{"nct_id":"NCT05760547","title":"The Translational Initiative to Map Epigenetics in Aging (TIME-A)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Elysium Health","has_results":false},{"nct_id":"NCT05540119","title":"Swedish Oesophago-Gastric Study","phase":"","overall_status":"UNKNOWN","enrollment_count":25000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04302207","title":"The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":20000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06092658","title":"Cohort Study of Chronic Heart Failure","phase":"","overall_status":"COMPLETED","enrollment_count":20000,"lead_sponsor_name":"Xiang Xie","has_results":false},{"nct_id":"NCT06284148","title":"Confidential IPV Screening Tool","phase":"NA","overall_status":"COMPLETED","enrollment_count":19655,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04033094","title":"Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)","phase":"","overall_status":"COMPLETED","enrollment_count":17566,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT06589843","title":"Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Xin Lou","has_results":false},{"nct_id":"NCT00797095","title":"Health Behaviors in School-age Children: 2009-2010","phase":"","overall_status":"COMPLETED","enrollment_count":12651,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT03280680","title":"Right to Health and Freedom From Violence","phase":"NA","overall_status":"COMPLETED","enrollment_count":11340,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT03407066","title":"Perception, Sensation, Cognition and Action in Humans","phase":"","overall_status":"RECRUITING","enrollment_count":10200,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04356365","title":"The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)","phase":"","overall_status":"COMPLETED","enrollment_count":10084,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT02707029","title":"Clinical and Scientific Assessment of Pain and Painful Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Center for Complementary and Integrative Health (NCCIH)","has_results":false},{"nct_id":"NCT03627572","title":"RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT00852904","title":"National Children s Health Study","phase":"","overall_status":"COMPLETED","enrollment_count":9942,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT03477877","title":"Indashyikirwa IPV Prevention Trial in Rwanda","phase":"NA","overall_status":"COMPLETED","enrollment_count":8909,"lead_sponsor_name":"Medical Research Council, South Africa","has_results":false},{"nct_id":"NCT05331248","title":"Training Local Leaders to Prevent and Reduce Domestic Violence Evidence From Peru","phase":"NA","overall_status":"COMPLETED","enrollment_count":8754,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT00898365","title":"Study of Kidney Tumors in Younger Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04106193","title":"Addressing Intimate Partner Violence Among Women Veterans","phase":"NA","overall_status":"COMPLETED","enrollment_count":7421,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT06507085","title":"Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology.","phase":"","overall_status":"RECRUITING","enrollment_count":6600,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04584424","title":"Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia","phase":"","overall_status":"COMPLETED","enrollment_count":6390,"lead_sponsor_name":"Ethiopian Public Health Institute","has_results":false},{"nct_id":"NCT03259646","title":"The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":6272,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03405675","title":"Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II)","phase":"","overall_status":"UNKNOWN","enrollment_count":6183,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT04744415","title":"Hospitalizations During Pandemia in the Italian Coronary Care Unit Network","phase":"","overall_status":"COMPLETED","enrollment_count":6054,"lead_sponsor_name":"Heart Care Foundation","has_results":false},{"nct_id":"NCT04492085","title":"National Survey of Workplace Violence","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Lei Li","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}